Skip to content

Reported April 30, 2024 · After market close

Revenue$10.1M
EPS-$0.45

Next report

Sep 10, 2026 (in a month)
Revenue estimate$29.0M
EPS estimate-$0.61

Financials

Q4 2024

Income statement

See full
Revenue$7.0M
Gross profit$90.5K
Operating income-$21.3M
Net income-$23.5M
EPS (diluted)-$1.27

Balance sheet

See full
Cash & equivalents$8.2M
Total debt$45.2M
Total assets$45.9M

Cash flow

See full
Operating cash flow-$18.1M
CapEx$3.1M
Free cash flow-$21.1M

Valuation & ratios

Profitability

See full
Gross margin1.3%
Operating margin-305.8%
Net margin-338.4%
FCF margin-303.7%

Returns & leverage

See full
Current ratio0.5×

Versus estimates

Ask the moment Kestra Medical Technologies, Ltd. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Kestra Medical Technologies, Ltd. report Q4 2024 earnings?
Kestra Medical Technologies, Ltd. (KMTS) reported Q4 2024 earnings on April 30, 2024 after market close.
What were Kestra Medical Technologies, Ltd.'s Q4 2024 revenue and EPS?
Kestra Medical Technologies, Ltd. reported revenue of $10.1M and eps of $-0.45 for Q4 2024.